Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the Toronto consensus

Gastroenterology
Brian BresslerToronto Ulcerative Colitis Consensus Group

Abstract

The medical management of ulcerative colitis (UC) has improved through the development of new therapies and novel approaches that optimize existing drugs. Previous Canadian consensus guidelines addressed the management of severe UC in the hospitalized patient. We now present consensus guidelines for the treatment of ambulatory patients with mild to severe active UC. A systematic literature search identified studies on the management of UC. The quality of evidence and strength of recommendations were rated according to the Grading of Recommendation Assessment, Development and Evaluation (GRADE) approach. Statements were developed through an iterative online platform and then finalized and voted on by a working group of specialists. The participants concluded that the goal of therapy is complete remission, defined as both symptomatic and endoscopic remission without corticosteroid therapy. The consensus includes 34 statements focused on 5 main drug classes: 5-aminosalicylate (5-ASA), corticosteroids, immunosuppressants, anti-tumor necrosis factor (TNF) therapies, and other therapies. Oral and rectal 5-ASA are recommended first-line therapy for mild to moderate UC, with corticosteroid therapy for those who fail to achieve remissio...Continue Reading

Associated Clinical Trials

References

Jul 4, 1992·BMJ : British Medical Journal·A B HawthorneJ E Lennard-Jones
Nov 1, 1990·The New England Journal of Medicine·A EkbomH O Adami
Dec 24, 1987·The New England Journal of Medicine·K W SchroederD M Ilstrup
Dec 14, 1974·British Medical Journal·D P Jewell, S C Truelove
Jun 1, 1995·Alimentary Pharmacology & Therapeutics·J K Marshall, E J Irvine
Jun 30, 1994·The New England Journal of Medicine·S LichtigerS Hanauer
Oct 1, 1995·Alimentary Pharmacology & Therapeutics·M LémannR Modigliani
Jun 1, 1996·Alimentary Pharmacology & Therapeutics·A A van BodegravenJ W Sindram
Mar 1, 1996·Scandinavian Journal of Gastroenterology·E LangholzV Binder
Aug 1, 1997·Annals of Internal Medicine·D J CookS R Weingarten
Mar 24, 1998·Diseases of the Colon and Rectum·P GionchettiM Campieri
Aug 5, 2000·The American Journal of Gastroenterology·J K Marshall, E J Irvine
Dec 9, 2000·European Journal of Gastroenterology & Hepatology·J Maté-JiménezR Moreno-Otero
Nov 6, 2001·The American Journal of Gastroenterology·S V KaneS B Hanauer
May 8, 2002·Journal of Gastroenterology·Ajit SoodVineeta Malhotra
Jan 25, 2003·The American Journal of Medicine·Sunanda KaneStephen Hanauer
Jul 9, 2003·Diseases of the Colon and Rectum·Simon Bar-MeirUNKNOWN International Budesonide Study Group
Feb 14, 1959·British Medical Journal·S C TRUELOVE, L J WITTS
Jan 23, 1965·Lancet·J E LENNARD-JONESF A JONES
Feb 11, 2005·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Erik J SchoonUNKNOWN Matrix Study Group
Apr 13, 2005·Gastroenterology·Robert W SummersJoel V Weinstock
Dec 13, 2005·The New England Journal of Medicine·Paul RutgeertsJean Frédéric Colombel
Apr 1, 2006·Alimentary Pharmacology & Therapeutics·R Bergman, M Parkes
Dec 5, 2006·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Dan TurnerAnne M Griffiths
Jan 24, 2007·Inflammatory Bowel Diseases·Javier P GisbertJosé Maté
Jun 9, 2007·The American Journal of Gastroenterology·Ole HöieUNKNOWN European Collaborative Study Group of Inflammatory Bowel Disease (EC-IBD)
Sep 11, 2007·Inflammatory Bowel Diseases·Geoffrey C NguyenSteven R Brant

❮ Previous
Next ❯

Citations

Nov 22, 2015·Expert Review of Gastroenterology & Hepatology·Andreas StallmachNiels Teich
Nov 19, 2015·Expert Review of Gastroenterology & Hepatology·Steven Lee-Kong, Ravi Pokala Kiran
Nov 17, 2015·Expert Opinion on Biological Therapy·Neal ShahidiRemo Panaccione
Dec 22, 2015·Gastroenterology·Geoffrey C NguyenUNKNOWN Canadian Association of Gastroenterology
Nov 26, 2015·Gastroenterology·Gilaad G Kaplan, Tine Jess
Sep 21, 2015·Current Gastroenterology Reports·Heba N IskandarFrancis A Farraye
Apr 23, 2016·Gastroenterology·Carlo A FalloneJohn K Marshall
May 25, 2016·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Michael Camilleri, David A Katzka
May 21, 2016·Inflammatory Bowel Diseases·Andrew R ReininkPeter D R Higgins
Aug 31, 2016·Inflammatory Bowel Diseases·Fernando LopesDerek M McKay
Oct 21, 2016·Inflammatory Bowel Diseases·Christian MottetPierre Michetti
Oct 25, 2016·Journal of Dairy Science·Daline Fernandes de Souza AraújoRita de Cássia Ramos do Egypto Queiroga
Oct 5, 2016·Clinical Journal of Gastroenterology·Makoto NaganumaTakanori Kanai
Oct 17, 2016·Gastroenterology·Adam S CheifetzPeter R Gibson
Dec 15, 2016·Expert Opinion on Biological Therapy·Fabio Salvatore MacalusoMario Cottone
Feb 1, 2017·The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi·Chang Hwan ChoiUNKNOWN IBD Study Group of the Korean Association for the Study of the Intestinal Diseases
Mar 11, 2017·Scandinavian Journal of Gastroenterology·Sabrina CardileGiuliano Torre
Oct 5, 2016·Journal of Gastroenterology and Hepatology·Jian ZengZhe-Chuan Mei
May 17, 2017·Inflammatory Bowel Diseases·Geoffrey C NguyenGil Y Melmed
Nov 24, 2016·European Journal of Gastroenterology & Hepatology·Jonas ZeitzMichael Scharl
Jul 2, 2016·Therapeutic Advances in Gastroenterology·M Anthony Sofia, David T Rubin
May 3, 2016·Therapeutic Advances in Gastroenterology·Neal ShahidiRemo Panaccione
Jul 12, 2017·Inflammatory Bowel Diseases·Andrei DanElham Rahme
Dec 12, 2017·Alimentary Pharmacology & Therapeutics·F P Colizzo, L S Friedman
Dec 23, 2017·Inflammatory Bowel Diseases·Sara van GennepMark Löwenberg
Mar 8, 2018·Alimentary Pharmacology & Therapeutics·A WilsonR B Kim
Mar 8, 2018·Alimentary Pharmacology & Therapeutics·N TeichA Stallmach
Oct 11, 2016·World Journal of Gastrointestinal Surgery·Rachel E Andrew, Evangelos Messaris
Nov 22, 2016·World Journal of Gastrointestinal Pharmacology and Therapeutics·Berrie MeijerNanne K H de Boer
Apr 19, 2018·Inflammatory Bowel Diseases·Berrie MeijerUNKNOWN Dutch Initiative on Crohn and Colitis (ICC) and Parelsnoer Institute
Jun 30, 2018·Expert Review of Gastroenterology & Hepatology·Samuele NaviglioAntonio Di Sabatino
May 17, 2018·Journal of Crohn's & Colitis·Christopher A LambEugene C Butcher
Aug 28, 2018·Current Opinion in Ophthalmology·Gurdeep Jhaj, Laura J Kopplin
Dec 6, 2017·The Nurse Practitioner·Stephanie C DavisJoseph S Lebel
Oct 5, 2018·Expert Review of Gastroenterology & Hepatology·Belinda Jackson, Peter De Cruz
Aug 14, 2018·Inflammatory Bowel Diseases·A Hillary SteinhartChadwick Williams

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Epidemiology
Joseph WatineChristine Augereau
Expert Opinion on Drug Metabolism & Toxicology
Jon Brendan Wiggins, Ramona Rajapakse
Pediatric Nephrology : Journal of the International Pediatric Nephrology Association
Rebecca M LombelKidney Disease: Improving Global Outcomes
© 2022 Meta ULC. All rights reserved